NCT07452939 · RECRUITING

Prefrontal Theta Burst Stimulation to Improve Cognitive Impairment After ICU Delirium

This pilot trial is testing whether a noninvasive brain stimulation technique called intermittent theta burst stimulation (iTBS) — essentially targeted magnetic pulses delivered through the scalp — can safely improve thinking and attention in adults who had delirium during an ICU stay. Participants receive 10 stimulation sessions over two weeks, about three months after discharge. This is a Phase NA pilot study, meaning the goal is to check safety and feasibility, not to prove the treatment works.

You may qualify if

  • Eligible individuals must have experienced an ICU admission with documented delirium (confirmed via documented Confusion Assessment Method for the ICU score12 [CAM-ICU] or Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition13(p5) [DSM-5] criteria)
  • Age 50 to 75 years old
  • 3 months post-ICU discharge at time of enrollment (defined as within 90 ± 14 days)
  • English fluency
  • Family or close friend for collateral
  • Community-dwelling status
  • Montreal Cognitive Assessment14 score between 18 and 25.

You're excluded if

  • Diagnosis of mild cognitive impairment or dementia (prior to delirium episode)
  • Seizure disorder
  • Other significant neurologic disease (e.g., Parkinson's, Huntington's, Normal pressure hydrocephalus, tumor, progressive supranuclear palsy, multiple sclerosis, hematomas, traumatic or anoxic brain injury)
  • Structural CT/MRI with evidence of infection or other clinically significant focal lesions (cortical strokes not large enough to distort anatomy and/or multiple lacunar infarctions ≤ 1.5cm and/or extensive white matter disease are allowed)
  • Unstable or decompensated cardiac disease (e.g., \<3 months myocardial infarction, unstable angina, decompensated congestive heart failure NYHA class 3-4)
  • Pacemaker
  • Cochlear implants
  • Implanted medication pumps
  • Intracranial metal implants
  • Previous TMS treatment
  • Pregnancy (negative urine or serum b-HCG or history of prior surgical sterilization or post-menopausal status [12 months or more of amenorrhea])
  • Current depressive disorder (Beck Depression Inventory score15 \<13)
  • History of suicide attempts
  • Schizophrenia
  • Bipolar disorder
  • Alcohol or substance abuse
  • Severe visual/hearing impairment.
  • Informant Questionnaire on Cognitive Decline in the Elderly16 (IQCODE) score ≥3.4 (suggesting prior cognitive decline)

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-03-11

View full record on ClinicalTrials.gov

All APOE4 clinical trials